Curaleaf (CURLF) faces a tough turnaround with high debt and limited cash; cannabis rescheduling could be the key catalyst. Read here for more analysis.
Haywood Securities analyst Neal Gilmer has reiterated his “Buy” rating and $5.00 price target on Curaleaf Holdings ...
If you are wondering whether Curaleaf Holdings at around US$3.11 is still offering value after its big swings, you are not alone and this article is built to help you unpack that. Over the past week ...
Zacks Investment Research on MSN
Earnings preview: Curaleaf Holdings, Inc. (CURLF) Q4 earnings expected to decline
Wall Street expects a year-over-year decline in earnings on lower revenues when Curaleaf Holdings, Inc. (CURLF) reports results for the quarter ended December 2025. While this widely-known consensus ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of ...
Curaleaf Holdings, Inc. (CURLF) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.02 per share a year ago. These ...
Beacon Securities analyst Russell Stanley is maintaining his “Buy” rating and C$5.00 price target on Curaleaf Holdings ...
STAMFORD, Conn., Feb. 9, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (CURA:CA) (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results